The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Business of Rheum Session to Outline What to Expect with MIPS Value Pathways

Business of Rheum Session to Outline What to Expect with MIPS Value Pathways

October 25, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Rheumatology plays a leading role among specialties included in the MIPS Value Pathways (MVPs), set to begin in 2023. With specialty-focused quality measures, the new payment model aims to streamline reporting and better target quality improvements.

You Might Also Like
  • Looking Forward to the Rheumatology MIPS Value Pathway
  • Annual Meeting Preview: Maximizing Reimbursement Under MACRA, MIPS & APMs
  • Virtual Groups: Another Option for Reporting MIPS Participation through RISE
Also By This Author
  • The ACR at 75: A Diamond Jubilee

Find out what you need to know to be ready for MVPs at an ACR Convergence 2021 session, Ahead of the Payment Curve: Keys for Reporting Success in the MIPS Value Pathway, to be held Tuesday, Nov. 9, at 9 a.m. EST.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The goal of MVPs is to simplify federal reporting for clinicians and incentivize quality improvement. With a new rheumatology-focused MVP, rheumatologists can assess their performance with targeted quality measures through the ACR’s RISE registry and access other ACR quality improvement resources.

“The MVP, which the Centers for Medicare & Medicaid Services recently proposed to push until 2023, will allow providers to submit two packages to the Quality Payment Program: MIPS and the MVPs,” says session moderator Angus B. Worthing, MD, FACP, FACR, a partner with Arthritis & Rheumatism Associates, Washington, D.C. “Medicare will calculate and use whichever is most advantageous to providers, so it’s worth learning about.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Succeeding in an Evolving System

“In this session, we attempt to distill what is important to know and things to watch for over the next several years,” says Kent “Kwas” Huston, MD, a rheumatologist with Kansas City Physician Partners in Kansas City, Missouri.

Drs. Worthing and Huston, along with William F. Harvey, MD, MSc, FACR, clinical director of the Arthritis Treatment Center and chief informatics medical officer at Tufts Medical Center, Boston, will review the recent history of value-based payment models and teach rheumatologists how MVPs—including the proposed rheumatology MVP—will work.

“The session is really about succeeding in the evolving payment system,” Dr. Harvey says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

One advantage of the MVP is that it will take the framework of the original MIPS structure and make it more cohesive, reducing the reporting burden, Dr. Harvey says. It also will make participation in the resulting pathways more meaningful to rheumatologists’ work, he says. “In other words, get credit for the hard work we already do to take care of our patients,” Dr. Harvey says.

Rheumatology’s Leading Role

After some early hesitation about the movement toward value-based care, the ACR decided to help lead the development of these models to have a better say in the process, Dr. Harvey says.

Now, as one of only seven specialties with currently approved MVPs, rheumatology will have an advantage with the new payment model, Dr. Huston says. “Most specialties still don’t have a starting point,” he says. Other specialties that will be included initially are stroke care and prevention, heart disease, chronic disease management, emergency medicine, lower extremity joint repair and anesthesia.

Pages: 1 2 | Single Page

Filed Under: ACR Convergence, Quality Assurance/Improvement Tagged With: ACR Convergence 2021, Angus Worthing, Kent “Kwas” Huston, MIPS Value Pathways, physician quality reporting, William Harvey

You Might Also Like:
  • Looking Forward to the Rheumatology MIPS Value Pathway
  • Annual Meeting Preview: Maximizing Reimbursement Under MACRA, MIPS & APMs
  • Virtual Groups: Another Option for Reporting MIPS Participation through RISE
  • Final Quarter for 2017 MIPS Reimbursement Has Begun

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)